Pancreatic Cancer Research

ResearcherUniversität UlmActive in the last 2 years

Hongzhen Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6400-0320; OpenAlex author ID A5100756890. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
46
Papers, trials and grants by year

2020: 1 paper · 2021: 3 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: 3 papers · 2026: 2 papers

Papers 10

  1. ALDH1A3 promotes the lung metastatic organotropism of pancreatic ductal adenocarcinoma through semaphorin signaling. Co-author DOI 10.1016/j.isci.2026.115950↗
  2. Paclitaxel and triptolide impair MYC-driven cell cycle via suppressing chromatin reprogramming in ALDH1A3High pancreatic cancer. Co-author DOI 10.1016/j.phymed.2026.158351↗
  3. Clinical characteristics of pancreatic cancer presenting with acute pancreatitis: a propensity-matched cohort study. Co-author DOI 10.1007/s00464-025-11654-z↗
  4. Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy. Co-author DOI 10.1016/j.xcrm.2024.101927↗
  5. ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network. Co-author DOI 10.1038/s41388-025-03530-w↗
  6. Triptolide exhibits dual anti-tumor effects through inhibiting autophagy and extracellular matrix activation in pancreatic cancer. Co-author DOI 10.4103/jcrt.jcrt_186_24↗
  7. AGR2-Dependent Nuclear Import of RNA Polymerase II Constitutes a Specific Target of Pancreatic Ductal Adenocarcinoma in the Context of Wild-Type p53. First author DOI 10.1053/j.gastro.2021.07.030↗
  8. Hypoxia promotes the metastasis of pancreatic cancer through regulating NOX4/KDM5A-mediated histone methylation modification changes in a HIF1A-independent man… Co-author DOI 10.1186/s13148-021-01016-6↗
  9. PPARγ/SOD2 Protects Against Mitochondrial ROS-Dependent Apoptosis via Inhibiting ATG4D-Mediated Mitophagy to Promote Pancreatic Cancer Proliferation. Co-author DOI 10.3389/fcell.2021.745554↗
  10. ALDH1A3 Accelerates Pancreatic Cancer Metastasis by Promoting Glucose Metabolism. Co-author DOI 10.3389/fonc.2020.00915↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuang Nie · 9 shared papers, 2020–2026 · strength 1.58
  2. Xiaoping Zou · 6 shared papers, 2020–2026 · strength 0.89
  3. Helmut Friess · 5 shared papers, 2021–2026 · strength 0.81
  4. Shanshan Shen · 6 shared papers, 2020–2025 · strength 0.77
  5. Xuetian Qian · 5 shared papers, 2020–2026 · strength 0.72
  6. Zhiheng Zhang · 3 shared papers, 2021–2025 · strength 0.43
  7. Christoph W. Michalski · 3 shared papers, 2021–2025 · strength 0.43
  8. Jorg H. Kleeff · 3 shared papers, 2021–2025 · strength 0.43
  9. Ying Lv · 3 shared papers, 2021–2025 · strength 0.41
  10. Bo Kong · 4 shared papers, 2020–2021 · strength 0.41
  11. Xiaoping Zou · 2 shared papers, 2021–2024 · strength 0.34
  12. Chao Fang · 2 shared papers, 2025 · strength 0.34
  13. Zipeng Lu · 2 shared papers, 2025 · strength 0.34
  14. Yifeng Sun · 2 shared papers, 2025 · strength 0.34
  15. Susanne Roth · 2 shared papers, 2025 · strength 0.34
  16. Christoph Kahlert · 2 shared papers, 2025 · strength 0.34
  17. Ingrid Herr · 2 shared papers, 2025 · strength 0.34
  18. Ying Lv · 2 shared papers, 2020–2026 · strength 0.34
  19. Shu Zhang · 3 shared papers, 2020–2021 · strength 0.31
  20. Helmut Frieß · 2 shared papers, 2020–2025 · strength 0.27
  21. Maximilian Reichert · 2 shared papers, 2021–2025 · strength 0.27
  22. Shanshan Shen · 1 shared paper, 2026 · strength 0.26
  23. André L. Mihaljević · 2 shared papers, 2021–2025 · strength 0.26
  24. Shanshan Shen · 1 shared paper, 2026 · strength 0.24
  25. J.-X. Gu · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.